Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Basic Clin Pharmacol Toxicol ; 123(6): 721-726, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29964362

ABSTRACT

The objective of this study was to evaluate the effect of apatinib on the pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in SD rats and the inhibitory effects of apatinib on venlafaxine in rat and human liver microsomes. Twenty-one SD male rats were randomly divided into three groups (n = 7): group A (multiple dose of 40 mg/kg apatinib for 7 days), group B (single dose of 40 mg/kg apatinib) and group C (the control group). All samples were measured by UPLC-MS/MS. The results indicated that a single dose of apatinib increased the AUC(0-t) , AUC(0-∞) and Cmax of both venlafaxine and O-desmethylvenlafaxine significantly, while Vz/F and CLz/F were decreased. As for group A, only AUC(0-t) and CLz/F of venlafaxine were changed, while no parameters of O-desmethylvenlafaxine were altered. In addition, apatinib was determined to be a mixed inhibitor of venlafaxine.


Subject(s)
Desvenlafaxine Succinate/pharmacokinetics , Protein Kinase Inhibitors/pharmacology , Pyridines/pharmacology , Venlafaxine Hydrochloride/pharmacokinetics , Animals , Chromatography, High Pressure Liquid , Desvenlafaxine Succinate/blood , Drug Interactions , Humans , Inhibitory Concentration 50 , Male , Mass Spectrometry , Microsomes, Liver/drug effects , Rats , Rats, Sprague-Dawley , Venlafaxine Hydrochloride/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...